Skip to main content

Sujani Ganga Surakanti

Assistant Professor of Medicine
Medicine, Medical Oncology

Selected Publications


When Treatment Can Harm Patients: Linaclotide-Induced Rhabdomyolysis

Conference American Journal of Gastroenterology · October 2017 Full text Cite

Reduction in Tumor Volume by Cone Beam Computed Tomography Predicts Overall Survival in Non-Small Cell Lung Cancer Treated With Chemoradiation Therapy.

Conference Int J Radiat Oncol Biol Phys · July 1, 2015 PURPOSE: We sought to evaluate whether tumor response using cone beam computed tomography (CBCT) performed as part of the routine care during chemoradiation therapy (CRT) could forecast the outcome of unresectable, locally advanced, non-small cell lung can ... Full text Link to item Cite

Impact of metformin use on survival in locally-advanced, inoperable non-small cell lung cancer treated with definitive chemoradiation

Journal Article Journal of Thoracic Disease · January 1, 2015 Background: We investigated survival outcomes in diabetic patients with non-small cell lung cancer (NSCLC) treated with concurrent metformin and definitive chemoradiation. Methods: This single-institution, retrospective cohort study included 166 patients w ... Full text Cite

Impact of Metformin Use on Survival in Non-Small Cell Lung Cancer Treated With Definitive Radiation Therapy

Conference International Journal of Radiation Oncology*Biology*Physics · September 2014 Full text Cite

Salivary gland malignancies: the role for chemotherapy and molecular targeted agents.

Journal Article Semin Oncol · June 2008 Salivary gland tumors are a rare and clinically diverse group of neoplasms that represent less than 1% of all malignancies. In locoregional recurrent or metastatic disease, systemic therapy is the standard approach. Numerous phase II studies with small sam ... Full text Link to item Cite